| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1483.48 | 97 |
| GSM780708 | Untreated after 4 days (C2_1) | 1217.86 | 96 |
| GSM780709 | Untreated after 4 days (C3_1) | 1202.31 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 2070.49 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 1004.95 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 720.782 | 94 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1028.73 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1804.26 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2015.89 | 98 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1256.13 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1198.65 | 96 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1010.76 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 2029.12 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1732.13 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1084.5 | 96 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1734.54 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1632.71 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1842.05 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 910.304 | 95 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1852.11 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1604.52 | 97 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1280.31 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1074.64 | 96 |